Onconova Therapeutics CEO Steven Fruchtman's 2022 pay falls 50% to $1.3M
Onconova Therapeutics reports 2022 executive compensation
By ExecPay News
Published: June 7, 2023
Onconova Therapeutics reported fiscal year 2022 executive compensation information on June 7, 2023.
In 2022, three executives at Onconova Therapeutics received on average a compensation package of $950K, a 44% decrease compared to previous year.
Average pay of disclosed executives at Onconova Therapeutics
Steven M. Fruchtman, Chief Executive Officer, received $1.3M in total, which decreased by 50% compared to 2021. 47% of Fruchtman's compensation, or $630K, was in salary. Fruchtman also received $252K in bonus, $303K in option awards, $116K in stock awards, as well as $26K in other compensation.
Mark P. Guerin, Chief Financial Officer, received a compensation package of $845K, which decreased by 35% compared to previous year. 54% of the compensation package, or $452K, was in salary.
Mark S. Gelder, Chief Medical Officer, earned $678K in 2022.
Related executives
You may also like
Source: SEC filing on June 7, 2023.